• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4594882)   Today's Articles (4726)   Subscriber (49326)
Number Citation Analysis
26
Lowes B, DePasquale E, Pinney S, Hsueh M, Fu Y, Shen L, Baran D, Kobashigawa J, Teuteberg J, Raval N. Higher Utilization of Non-Invasive Rejection Surveillance in Year Two after Heart Transplant is Associated with Higher Rates of Detection Of Rejection, Graft Dysfunction, and Vasculopathy. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]  Open
27
Han J, Nguyen A, Tian W, Nguyen A, Zeng J, Shen L, DePasquale E, Patel S. Effect of Pre-Transplant Sensitization on Gene Expression Profiling and Donor Derived Cell Free DNA Results. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]  Open
28
Han J, Nguyen A, Zhou M, Nguyen A, Fu Y, Shen L, Patel S, DePasquale E. Association of Early Testing of Donor Derived Cell-Free DNA with the Risk of Antibody Mediated Rejection in Heart Transplant Recipients. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]  Open
29
Liu YF, Ding RJ, Meng XP, Wang LM, Shen XY, Shen L, Cai XJ, Yue RH, Shen YQ, Xu DY, Hu DY. [Self-reported quality of life in patients with coronary heart disease and analysis of the associated factors]. ZHONGHUA NEI KE ZA ZHI 2023;62:384-392. [PMID: 37032133 DOI: 10.3760/cma.j.cn112138-20220524-00404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/11/2023]
30
Bellumkonda L, Uriel N, Fu Y, Shen L, Qu K, Baran D. Impact of Steroid Withdrawal on Gene Expression Profiling, Donor Derived Cell-Free DNA, and Clinical Outcomes in the SHORE Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]  Open
31
Li YF, Yang WL, Wei WB, Yang LL, Xu XL, Zhang X, Wang Q, Wang S, Li DJ, Wang ZY, Chen W, Zhao Q, Cui R, Shen L, Liu Q. [Ultrasonographic features of retinal pigment epithelial adenoma]. [ZHONGHUA YAN KE ZA ZHI] CHINESE JOURNAL OF OPHTHALMOLOGY 2023;59:181-186. [PMID: 36860104 DOI: 10.3760/cma.j.cn112142-20220803-00382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
32
Shen L, Lu S. [Chemotherapy induced anemia]. ZHONGHUA NEI KE ZA ZHI 2023;62:242-246. [PMID: 36822848 DOI: 10.3760/cma.j.cn112138-20230110-00011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
33
CHEN X, Xiao J, Tao D, Liang Y, Chen S, Shen L, Li S, Zheng Z, Zeng Y, Luo C, Peng F, Long H. WCN23-0693 METADHERIN PROMOTES PODOCYTE INJURY AND PROTEINURIA THROUGH ACTIVATING cAMP/PKA/β-CATENIN SIGNALING. Kidney Int Rep 2023. [DOI: 10.1016/j.ekir.2023.02.491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/22/2023]  Open
34
Law Y, Shen L, Khor V, Chen W, Chen W, Durai P, Gauhar V, Lie K, Lee K. Choosing the best way for urinary decompression and developing a novel predictive model for septic shock using Sequential Organ Failure Assessment (SOFA) in these patients. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00191-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
35
Jiang YH, Shen L, Liu QB, Dai XY, Sheng J, Liu XY. [Evaluation of uniportal video-assisted thoracoscopic decortication in treatment of drug-resistant tuberculous empyema]. ZHONGHUA WAI KE ZA ZHI [CHINESE JOURNAL OF SURGERY] 2023;61:156-161. [PMID: 36720626 DOI: 10.3760/cma.j.cn112139-20220519-00231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
36
Delgado P, Oshinowo O, Fay ME, Luna CA, Dissanayaka A, Dorbala P, Ravindran A, Shen L, Myers DR. Universal pre-mixing dry-film stickers capable of retrofitting existing microfluidics. BIOMICROFLUIDICS 2023;17:014104. [PMID: 36687143 PMCID: PMC9848651 DOI: 10.1063/5.0122771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Accepted: 12/12/2022] [Indexed: 06/17/2023]
37
Han C, Ye S, Hu C, Shen L, Qin Q, Bai Y, Yang S, Bai C, Zang A, Jiao S, Bai L. 80P Penpulimab (Anti-PD-1) combined with anlotinib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): Updated overall survival results from a phase Ib/II study. IMMUNO-ONCOLOGY AND TECHNOLOGY 2022. [DOI: 10.1016/j.iotech.2022.100184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
38
Wang Y, Xia F, Shen L, Wan J, Zhang H, Wu R, Wang J, Wang Y, Xu Y, Cai S, Zhang Z. Short-Course Radiotherapy Based Total Neoadjuvant Therapy Combined with Toripalimab for Locally Advanced Rectal Cancer: Preliminary Findings from a Randomized, Prospective, Multicenter, Double-Arm, Phase II Trial (TORCH). Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
39
Shen L, Hong D, Tahara M, Baik C, Bauman J, Gilbert J, Brose M, Grilley-Olson J, Patil T, McDermott R, Raez L, Johnson J, Norenberg R, Dima L, Mussi C, Le X, Drilon A. 222O Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]  Open
40
Chen Y, Yu L, Zhou Y, Shen L, Kovalchuk N, Xing L, Han B, Gensheimer M. Systematic Study of Patient-Specific Organs at Risk Auto-Segmentation on Daily kVCT Images for Adaptive Head and Neck Radiotherapy. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.2272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
41
Vasudevan V, Shen L, Huang C, Chuang C, Islam M, Ren H, Yang Y, Dong P, Xing L. Neural Representation for Three-Dimensional Dose Distribution and its Applications in Precision Radiation Therapy. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.2182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
42
Kim SB, Van Cutsem E, Ajani J, Shen L, Barnes G, Ding N, Tao A, Xia T, Zhan L, Kato K. 80P RATIONALE-302: Tislelizumab vs chemotherapy as second-line treatment for patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC): Impact on health-related quality of life (HRQoL) in Asian patients. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]  Open
43
Liu L, Shen L, Xing L. Neural Representation of Linear Accelerator Beam Data from a Single Reference Dataset for Fast Commissioning and Quality Assurance. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
44
Kato K, Yoon H, Raymond E, Hubner R, Shu Y, Pan Y, Park S, Ping L, Jiang Y, Zhang J, Wu X, Yao Y, Shen L, Kojima T, Lin CY, Wang L, Tao A, Peng Y, Li L, Xu J. 70O Randomized, global, phase III study of tislelizumab (TIS) + chemotherapy (chemo) vs chemo as first-line (1L) therapy for advanced or metastatic esophageal squamous cell carcinoma (ESCC) (RATIONALE-306): Asia subgroup. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]  Open
45
Su X, Huo H, Zeng Y, Liu M, Shen L, Fu X, Cai X. Effective Echocardiography Parameters to Identify Radiation-Induced Heart Disease in the Mouse Model. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.2098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
46
Omar GJ, Kong WL, Jani H, Li MS, Zhou J, Lim ZS, Prakash S, Zeng SW, Hooda S, Venkatesan T, Feng YP, Pennycook SJ, Shen L, Ariando A. Experimental Evidence of t_{2g} Electron-Gas Rashba Interaction Induced by Asymmetric Orbital Hybridization. PHYSICAL REVIEW LETTERS 2022;129:187203. [PMID: 36374676 DOI: 10.1103/physrevlett.129.187203] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Accepted: 09/28/2022] [Indexed: 06/16/2023]
47
Lu M, Wang Y, Zhang P, Shen L. 499TiP Surufatinib combined with sintilimab and IBI310 in the treatment of high-grade advanced-neuroendocrine neoplasm: A single arm, open-label, multicenter study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]  Open
48
Wang L, Qin S, Zhou Y, Zhang S, Sun X, Chen Z, Cui J, Zhao P, Gu K, Li Z, Wang J, Chen X, Yao J, Shen L, Zhou J, Wang G, Bai Y, Wang Q, Wang H. LBA61 HR070803 plus 5-FU/LV versus placebo plus 5-FU/LV in second-line therapy for gemcitabine-refractory locally advanced or metastatic pancreatic cancer: A multicentered, randomized, double-blind, parallel-controlled phase III trial (HR-IRI-APC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.08.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
49
Shen L, Gong J, Niu Z, Zhao R, L. Chen, L. Liu, Deng T, L. Lu, Zhang Y, Z. Li, X. Li, B. Xia. 1210P The preliminary efficacy and safety of KN026 combined with KN046 treatment in HER2-positive locally advanced unresectable or metastatic gastric/gastroesophageal junction cancer without prior systemic treatment in a phase II study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
50
Harding J, Hofheinz R, Elez Fernandez M, Kuboki Y, Rasco D, Cecchini M, Shen L, Archuadze S, Geng J, Haderk F, Pant S. 371P A phase Ia/b, open-label, multicentre study of the TRAILR2 agonist BI 905711 in patients (pts) with advanced gastrointestinal (GI) cancers. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
PrevPage 2 of 36 123453536Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA